Since 2009, I joined the National Center for Genetic Engineering and Biotechnology ( BIOTEC, NSTDA) , Thailand, there, I was given the opportunity to learn the deep ends of scientific research, to which am now dedicated. My research group focuses on development of antimalarial drug. My major research interest is on the generation of transgenic Plasmodium berghei as models for drug screening in animals. I was also involved in the construction of transfection of the plasmids into P. berghei by using the CRISPR/ Cas9 system. Over the years I have been saddled with the core responsibilities of developing and managing the in vivo components of compound testing towards the discovery of novel antimalarial compounds by the group. I also played supporting roles in every project in the lab that uses animal laboratory technique such as pharmacokinetic study of novel antimalarial compounds. I have decided to resign from my work at BIOTEC in December, 2019, to undertake the PhD. program in veterinary science, Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, which is renowned and reputable in animal health innovation. I recived my Ph.D. degree in December, 2022 and continuous research at the same laboratory. Although, my major research interest is on the effect of componuds against Babesia infections in cattle, I also involved in the animal vaccine development projects. I hope any knowledge from my research will benefit animal health and veterinary science.